Societal preferences for adjuvant melanoma health states: UK and Australia

BACKGROUND: No studies have measured preference-based utility weights for specific toxicities and outcomes associated with approved and investigational adjuvant treatments for patients with resected high-risk melanoma. METHODS: A cross-sectional study was conducted in the United Kingdom and Australi...

Descripción completa

Detalles Bibliográficos
Autores principales: Middleton, Mark R., Atkins, Michael B., Amos, Kaitlan, Wang, Peter Feng, Kotapati, Srividya, Sabater, Javier, Beusterien, Kathleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646133/
https://www.ncbi.nlm.nih.gov/pubmed/29041898
http://dx.doi.org/10.1186/s12885-017-3673-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646133/
https://www.ncbi.nlm.nih.gov/pubmed/29041898
http://dx.doi.org/10.1186/s12885-017-3673-y

Ejemplares similares